Related references
Note: Only part of the references are listed.The Association of Medications and Vaccination with Risk of Pneumonia in Inflammatory Bowel Disease
Martin H. Gregory et al.
INFLAMMATORY BOWEL DISEASES (2020)
AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis
Joseph D. Feuerstein et al.
GASTROENTEROLOGY (2020)
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention
Zunyou Wu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Clinical Characteristics of Coronavirus Disease 2019 in China
W. Guan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Daniel Wrapp et al.
SCIENCE (2020)
The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Sudabeh Alatab et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China
L. Zhang et al.
ANNALS OF ONCOLOGY (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Managing Inflammatory Bowel Disease During COVID-19: Summary of Recommendations from Gastrointestinal Societies
Jurij Hanzel et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Incidence and Patterns of COVID-19 Among Inflammatory Bowel Disease Patients From the Nancy and Milan Cohorts
Mariangela Allocca et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
SARS-CoV-2 Testing, Prevalence, and Predictors of COVID-19 in Patients with Inflammatory Bowel Disease in Northern California
John Gubatan et al.
GASTROENTEROLOGY (2020)
Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry
Erica J. Brenner et al.
GASTROENTEROLOGY (2020)
AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary
David T. Rubin et al.
GASTROENTEROLOGY (2020)
Management of Patients with Crohn’s Disease and Ulcerative Colitis During the COVID-19 Pandemic: Results of an International Meeting
David T. Rubin et al.
GASTROENTEROLOGY (2020)
Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study
Cristina Bezzio et al.
GUT (2020)
British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic
Nicholas A. Kennedy et al.
GUT (2020)
Expression of SARS-CoV-2 Entry Molecules ACE2 and TMPRSS2 in the Gut of Patients With IBD
Juan F. Burgueno et al.
INFLAMMATORY BOWEL DISEASES (2020)
Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality
Chi Zhang et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China
Ruchong Chen et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed
Marc Feldmann et al.
LANCET (2020)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou et al.
LANCET (2020)
Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection
Zou Xin et al.
FRONTIERS OF MEDICINE (2020)
Obesity and impaired metabolic health in patients with COVID-19
Norbert Stefan et al.
NATURE REVIEWS ENDOCRINOLOGY (2020)
Clinical Characteristics of Covid-19 in New York City
Parag Goyal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Coronavirus Disease 2019 Pneumonia in Immunosuppressed Renal Transplant Recipients: A Summary of 10 Confirmed Cases in Wuhan, China
Lan Zhu et al.
EUROPEAN UROLOGY (2020)
Increased Risk of Influenza and Influenza-Related Complications Among 140,480 Patients With Inflammatory Bowel Disease
Andrew Tinsley et al.
INFLAMMATORY BOWEL DISEASES (2019)
Tocilizumab for the treatment of chimeric antigen receptor T cell-induced cytokine release syndrome
Chelsea Kotch et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2019)
ACG Clinical Guideline: Management of Crohn's Disease in Adults
Gary R. Lichtenstein et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2018)
Risk of serious infection in healthcare workers with inflammatory bowel disease: a case-control study of the Groupe d'Etude Therapeutique des Affections Inflammatoires du tube Digestif (GETAID)
Charlotte Gagniere et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Adjuvant use of antibiotics with corticosteroids in inflammatory bowel disease exacerbations requiring hospitalisation: a retrospective cohort study and meta-analysis
V. Gupta et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Increased Risk of Pneumonia Among Patients With Inflammatory Bowel Disease
Millie D. Long et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Older Age Is Associated with Higher Rate of Discontinuation of Anti-TNF Therapy in Patients with Inflammatory Bowel Disease
Amit Desai et al.
INFLAMMATORY BOWEL DISEASES (2013)
Increased risk of pneumonia among patients with inflammatory bowel disease: A comparison between patients treated with biologic therapies and with conventional drugs
Claudia Romano et al.
JOURNAL OF CROHNS & COLITIS (2013)
Direct Health Care Costs of Crohn's Disease and Ulcerative Colitis in US Children and Adults
Michael D. Kappelman et al.
GASTROENTEROLOGY (2008)
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
WH Li et al.
NATURE (2003)
Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme
D Harmer et al.
FEBS LETTERS (2002)